Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07046013

Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

Relation Between Serum Lactate Dehydrogenase and Immune Thrombocytopenia

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia

Detailed description

Immune thrombocytopenia is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Lactate dehydrogenase is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate. The LDH was found to be moderately high in patients with immune thrombocytopenia at the time of diagnosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLactate dehydrogenaseIt's elevation at the time of diagnosis

Timeline

Start date
2025-08-01
Primary completion
2027-06-01
Completion
2027-07-01
First posted
2025-07-01
Last updated
2025-07-01

Source: ClinicalTrials.gov record NCT07046013. Inclusion in this directory is not an endorsement.